Back to search

Article

ATP-citrate lyase as a therapeutic target in chronic kidney disease: a Mendelian Randomization analysis

2021-10-11

Abstract excerpt

<h4>Background</h4> ATP-citrate lyase (ACLY) inhibition is a promising therapeutic target for dyslipidemia, atherosclerotic cardiovascular disease, non-alcoholic steatohepatitis, and metabolic syndrome. Genetic analysis of its role in chronic kidney disease (CKD) has not been performed. <h4>Methods</h4> We constructed a genetic instrument by selecting variants associated with ACLY expression level in the expressio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
60dd6786-2ef9-53df-8a41-93bd51eb6c7e
DOI
10.1101/2021.10.07.21264710
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ATP-citrate lyase as a therapeutic target in chronic kidney disease: a Mendelian Randomization analysisDOI 10.1101/2021.10.07.21264710
Select a neighboring publication to make it the new centre.